Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
683.00 GBX | +0.44% |
|
-5.47% | +12.15% |
06-13 | E24: Experts see risk of bankruptcy at XXL | FW |
06-12 | Revolution Beauty in talks for takeover offers, equity raise | AN |
Fiscal Period: April | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.55 | 3.99 | 8.56 | 6.49 | 7.42 | |||||
Return on Total Capital | 5.1 | 5.61 | 12.58 | 9.37 | 10.12 | |||||
Return On Equity % | 7.98 | -6.26 | 20.39 | 33.79 | 22.54 | |||||
Return on Common Equity | 7.46 | -6.75 | 20.15 | 33.6 | 22.65 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 42.01 | 42.14 | 43.64 | 42.86 | 43.62 | |||||
SG&A Margin | 30.5 | 27.94 | 33.06 | 35.45 | 33.94 | |||||
EBITDA Margin % | 9.53 | 12.95 | 15.1 | 11.54 | 13.03 | |||||
EBITA Margin % | 5.37 | 6.93 | 11.46 | 7.99 | 9.43 | |||||
EBIT Margin % | 5.04 | 6.74 | 11.3 | 7.87 | 9.39 | |||||
Income From Continuing Operations Margin % | 2.55 | -2.15 | 5.35 | 9.01 | 7.21 | |||||
Net Income Margin % | 2.37 | -2.29 | 5.2 | 8.77 | 6.88 | |||||
Net Avail. For Common Margin % | 2.37 | -2.29 | 5.2 | 8.77 | 7.1 | |||||
Normalized Net Income Margin | 3.54 | 4.94 | 7.24 | 5.69 | 6.11 | |||||
Levered Free Cash Flow Margin | 4.41 | 7.57 | -3.15 | 1.65 | 7.35 | |||||
Unlevered Free Cash Flow Margin | 4.88 | 8.11 | -2.73 | 2.33 | 8.31 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.13 | 0.95 | 1.21 | 1.32 | 1.26 | |||||
Fixed Assets Turnover | 3.65 | 2.89 | 4.42 | 5.15 | 5.29 | |||||
Receivables Turnover (Average Receivables) | 41.14 | 41.36 | 24.01 | 17.85 | 18.27 | |||||
Inventory Turnover (Average Inventory) | 2.11 | 1.83 | 2.28 | 2.32 | 2.21 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.62 | 2.28 | 2.54 | 2.55 | 2.57 | |||||
Quick Ratio | 0.97 | 0.83 | 0.8 | 0.77 | 0.84 | |||||
Operating Cash Flow to Current Liabilities | 0.44 | 0.55 | 0.49 | 0.53 | 0.71 | |||||
Days Sales Outstanding (Average Receivables) | 8.85 | 8.8 | 15.16 | 20.78 | 19.92 | |||||
Days Outstanding Inventory (Average Inventory) | 172.63 | 199.12 | 159.56 | 159.98 | 164.41 | |||||
Average Days Payable Outstanding | 39.67 | 53.68 | 40.31 | 40.38 | 42.48 | |||||
Cash Conversion Cycle (Average Days) | 141.81 | 154.24 | 134.41 | 140.39 | 141.85 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 119.04 | 117.97 | 110.69 | 86.21 | 77.55 | |||||
Total Debt / Total Capital | 54.35 | 54.12 | 52.54 | 46.3 | 43.68 | |||||
LT Debt/Equity | 107.49 | 102.4 | 101.75 | 79 | 71.54 | |||||
Long-Term Debt / Total Capital | 49.07 | 46.98 | 48.29 | 42.42 | 40.29 | |||||
Total Liabilities / Total Assets | 66.9 | 68.01 | 68.41 | 61.37 | 57.96 | |||||
EBIT / Interest Expense | 6.83 | 7.76 | 16.56 | 7.22 | 6.09 | |||||
EBITDA / Interest Expense | 20.44 | 17.51 | 24.48 | 11.82 | 9.42 | |||||
(EBITDA - Capex) / Interest Expense | 9.36 | 10.54 | 14.63 | 4.09 | 6.3 | |||||
Total Debt / EBITDA | 2.55 | 2.59 | 1.8 | 1.99 | 1.8 | |||||
Net Debt / EBITDA | 1.66 | 1.76 | 1.38 | 1.49 | 1.33 | |||||
Total Debt / (EBITDA - Capex) | 5.57 | 4.3 | 3.02 | 5.76 | 2.7 | |||||
Net Debt / (EBITDA - Capex) | 3.62 | 2.93 | 2.32 | 4.31 | 2 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 6.9 | -8.39 | 32.55 | 15.81 | -0.86 | |||||
Gross Profit, 1 Yr. Growth % | 5 | -8.11 | 37 | 13.74 | 0.22 | |||||
EBITDA, 1 Yr. Growth % | 27.34 | 19.2 | 53.19 | -11.49 | 12.24 | |||||
EBITA, 1 Yr. Growth % | 23.6 | 9.6 | 115.67 | -19.21 | 14.52 | |||||
EBIT, 1 Yr. Growth % | 16.68 | 13.15 | 118.55 | -19.37 | 15.88 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -12.93 | -177.23 | -429.36 | 95.13 | -16.63 | |||||
Net Income, 1 Yr. Growth % | -16.25 | -188.49 | -400.96 | 95.36 | -22.55 | |||||
Normalized Net Income, 1 Yr. Growth % | 4.76 | 19.23 | 75.54 | -9.04 | 4.62 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -13.95 | -189.38 | -360.99 | 111.37 | -11.37 | |||||
Accounts Receivable, 1 Yr. Growth % | -9.32 | -8.42 | 274.76 | -5.91 | 0.68 | |||||
Inventory, 1 Yr. Growth % | 22.48 | -8.49 | 16.51 | 14.66 | -7.48 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 63.7 | -13.56 | -13.21 | 13.82 | -14.96 | |||||
Total Assets, 1 Yr. Growth % | 22.85 | -2.15 | 9.45 | 3.62 | 3.54 | |||||
Tangible Book Value, 1 Yr. Growth % | 2.77 | -4.58 | 8.73 | 36.72 | 12.37 | |||||
Common Equity, 1 Yr. Growth % | 1.66 | -5.87 | 7.85 | 25.77 | 13.3 | |||||
Cash From Operations, 1 Yr. Growth % | 37.83 | 37.78 | -2.14 | -12.74 | 25.94 | |||||
Capital Expenditures, 1 Yr. Growth % | 104.1 | -32.18 | 47.31 | 45.24 | -43.08 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -139.1 | 48.39 | -154.4 | -160.58 | 360.53 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -144.38 | 44.75 | -143.93 | -199.04 | 264.66 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 8.53 | -1.04 | 10.19 | 23.9 | 7.35 | |||||
Gross Profit, 2 Yr. CAGR % | 11.59 | -1.78 | 12.31 | 24.83 | 7.33 | |||||
EBITDA, 2 Yr. CAGR % | 8.48 | 25.87 | 35.73 | 16.45 | -0.28 | |||||
EBITA, 2 Yr. CAGR % | 11.96 | 20.83 | 55.03 | 32.01 | -2.64 | |||||
EBIT, 2 Yr. CAGR % | 10 | 19.56 | 58.6 | 32.76 | -2.14 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 108.65 | -18 | 59.49 | 153.51 | 24.64 | |||||
Net Income, 2 Yr. CAGR % | 116.02 | -13.91 | 63.19 | 142.48 | 23.47 | |||||
Normalized Net Income, 2 Yr. CAGR % | 16.97 | 15.81 | 52.17 | 26.36 | -1.39 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 120.64 | -12.3 | 60.24 | 134.87 | 37.41 | |||||
Accounts Receivable, 2 Yr. CAGR % | -6.56 | -8.87 | 85.48 | 87.72 | -2.67 | |||||
Inventory, 2 Yr. CAGR % | 17.13 | 5.87 | 3.26 | 15.58 | 3 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 25.03 | 18.96 | -13.38 | -0.61 | -2.42 | |||||
Total Assets, 2 Yr. CAGR % | 15.67 | 9.64 | 3.49 | 6.49 | 3.7 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.33 | -0.97 | 1.86 | 21.92 | 24.34 | |||||
Common Equity, 2 Yr. CAGR % | 3.01 | -2.18 | 0.76 | 16.47 | 19.74 | |||||
Cash From Operations, 2 Yr. CAGR % | 7.46 | 37.8 | 16.12 | 2.16 | 4.83 | |||||
Capital Expenditures, 2 Yr. CAGR % | 25.87 | 17.65 | -0.05 | 46.27 | -9.08 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 93.66 | -21.61 | -9.51 | -42.61 | 63.97 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 144.77 | -17.73 | -19.73 | -34.05 | 87.55 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.84 | 2.57 | 9.09 | 12.04 | 15.17 | |||||
Gross Profit, 3 Yr. CAGR % | 7.71 | 4.59 | 9.82 | 12.79 | 16.43 | |||||
EBITDA, 3 Yr. CAGR % | 19.86 | 13.55 | 34.78 | 17.71 | 15.07 | |||||
EBITA, 3 Yr. CAGR % | 26.71 | 13.97 | 47.38 | 24.76 | 26.92 | |||||
EBIT, 3 Yr. CAGR % | 27.06 | 14.02 | 47.02 | 26.59 | 27.92 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -24.18 | 49.81 | 30.35 | 70.58 | 72.32 | |||||
Net Income, 3 Yr. CAGR % | -25.83 | 60.43 | 30.65 | 73.28 | 66.16 | |||||
Normalized Net Income, 3 Yr. CAGR % | -5.74 | 20.54 | 37.59 | 28.19 | 19.51 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -21.54 | 63.26 | 30.24 | 75.73 | 70.17 | |||||
Accounts Receivable, 3 Yr. CAGR % | 4.54 | -7.18 | 46.12 | 47.9 | 52.51 | |||||
Inventory, 3 Yr. CAGR % | 21.13 | 7.88 | 9.3 | 6.93 | 7.32 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 16.97 | 10.56 | 7.09 | -5.13 | -6.16 | |||||
Total Assets, 3 Yr. CAGR % | 16.46 | 9.4 | 9.58 | 3.53 | 5.58 | |||||
Tangible Book Value, 3 Yr. CAGR % | 2.19 | 1.92 | 2.16 | 12.36 | 18.9 | |||||
Common Equity, 3 Yr. CAGR % | 0.76 | -0.04 | 1.06 | 8.49 | 15.64 | |||||
Cash From Operations, 3 Yr. CAGR % | 13.53 | 16.74 | 22.95 | 12.87 | 9.54 | |||||
Capital Expenditures, 3 Yr. CAGR % | -7.86 | 2.42 | 26.81 | 13.21 | 6.79 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 22.88 | 80.63 | -30.27 | -20.85 | 13.5 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 29.69 | 109.05 | -32.96 | -13.92 | 15.59 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 6.92 | 4.53 | 8.17 | 10.62 | 8.39 | |||||
Gross Profit, 5 Yr. CAGR % | 6.03 | 3.53 | 9.53 | 12.31 | 8.81 | |||||
EBITDA, 5 Yr. CAGR % | 0.2 | 4.79 | 27.06 | 14.91 | 19.48 | |||||
EBITA, 5 Yr. CAGR % | -7.31 | -2.32 | 39.43 | 21.27 | 24.86 | |||||
EBIT, 5 Yr. CAGR % | -7.72 | -2.4 | 41.07 | 21.59 | 24.94 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -15.99 | -22.5 | 2.09 | 84.89 | 28.03 | |||||
Net Income, 5 Yr. CAGR % | -17.16 | -21.44 | 1.67 | 89.25 | 27.73 | |||||
Normalized Net Income, 5 Yr. CAGR % | -6.6 | -6.91 | 15.8 | 25.34 | 20.42 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -13.86 | -18.33 | 4.4 | 92.48 | 33.06 | |||||
Accounts Receivable, 5 Yr. CAGR % | 3.13 | 8.55 | 31.49 | 23.08 | 24.18 | |||||
Inventory, 5 Yr. CAGR % | 18.31 | 9.32 | 13.64 | 10.9 | 6.73 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 26.09 | 14.73 | 3.73 | 5.95 | 3.18 | |||||
Total Assets, 5 Yr. CAGR % | 16.88 | 9.91 | 11.09 | 8.23 | 7.19 | |||||
Tangible Book Value, 5 Yr. CAGR % | 4.34 | -1.86 | 2.05 | 9.49 | 10.51 | |||||
Common Equity, 5 Yr. CAGR % | 1.71 | -2.96 | 0.76 | 6.26 | 8.15 | |||||
Cash From Operations, 5 Yr. CAGR % | 9.72 | 51.19 | 14.56 | 10.68 | 20.08 | |||||
Capital Expenditures, 5 Yr. CAGR % | 27.15 | 1.17 | -4.81 | 18.11 | 11.01 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 166.97 | 37.49 | 9.98 | 14.51 | -1.84 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 130.11 | 42.09 | 8.17 | 32.12 | 1.16 |
- Stock Market
- Equities
- FRAS Stock
- Financials Frasers Group Plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition